PBH Prestige Consumer Healthcare Inc

  1. Stocks
  2. Healthcare
  3. NYSE: PBH

Price (delayed)

$45.23

Market cap

$2.14B

P/E Ratio

11.51

Dividend/share

N/A

EPS

$3.93

Enterprise value

$3.12B

?
Relative Growth: Rel. Growth: 24
Relative Strength: Rel. Strength: 8
Relative Valuation: Rel. Valuation: 74
Relative Profitability: Rel. Profitability: 72

Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company's diverse portfolio ...

Highlights
PBH's P/E is 29% below its last 4 quarters average of 16.3 and 28% below its 5-year quarterly average of 16.0
The equity has grown by 3.2% from the previous quarter and by 2.9% YoY
The quick ratio has decreased by 23% YoY but it has increased by 17% from the previous quarter
The net income has contracted by 11% YoY but it has grown by 2% from the previous quarter
Prestige Consumer Healthcare's gross profit has decreased by 6% YoY and by 3.8% QoQ
Prestige Consumer Healthcare's revenue has decreased by 4.3% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.prestigebrands.com
Peers: PFE PG NVS JNJ

Key stats

What are the main financial stats of PBH

PBH stock price

How has the Prestige Consumer Healthcare stock price performed over time
Intraday
-0.46%
1 week
-6.68%
1 month
-18.22%
1 year
-46.66%
YTD
-26.68%
QTD
-23.69%

Financial performance

How have Prestige Consumer Healthcare's revenue and profit performed over time
Revenue
$1.09B
Gross profit
$595.58M
Operating income
$309.41M
Net income
$190.3M
Gross margin
54.7%
Net margin
17.5%
The net income has contracted by 11% YoY but it has grown by 2% from the previous quarter
The company's operating income fell by 8% YoY and by 4% QoQ
The company's net margin fell by 7% YoY but it rose by 3.6% QoQ
Prestige Consumer Healthcare's gross profit has decreased by 6% YoY and by 3.8% QoQ

Price vs fundamentals

How does PBH's price correlate with its fundamentals

Growth

What is Prestige Consumer Healthcare's growth rate over time

Valuation

What is Prestige Consumer Healthcare stock price valuation
PBH P/E details
P/E
11.51
P/B
1.13
P/S
2.01
EV/EBIT
10.41
EV/EBITDA
9.21
EV/Sales
2.87
PBH's P/E is 29% below its last 4 quarters average of 16.3 and 28% below its 5-year quarterly average of 16.0
The EPS has contracted by 9% YoY but it has grown by 3.1% from the previous quarter
PBH's price to book (P/B) is 40% lower than its 5-year quarterly average of 1.9 and 33% lower than its last 4 quarters average of 1.7
The equity has grown by 3.2% from the previous quarter and by 2.9% YoY
The price to sales (P/S) is 30% lower than the 5-year quarterly average of 2.9 and 30% lower than the last 4 quarters average of 2.9
Prestige Consumer Healthcare's revenue has decreased by 4.3% YoY

Efficiency

How efficient is Prestige Consumer Healthcare business performance
PBH's ROE is down by 16% YoY
Prestige Consumer Healthcare's return on assets has decreased by 14% YoY
Prestige Consumer Healthcare's ROIC has decreased by 13% YoY and by 3.7% from the previous quarter
The ROS has contracted by 6% YoY

Dividends

What is PBH's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Prestige Consumer Healthcare financials performed over time
Prestige Consumer Healthcare's total assets is 117% higher than its total liabilities
The quick ratio has decreased by 23% YoY but it has increased by 17% from the previous quarter
The current ratio has declined by 15% year-on-year but it is up by 15% since the previous quarter
The company's debt is 45% lower than its equity
Prestige Consumer Healthcare's debt to equity has decreased by 7% from the previous quarter and by 3.5% YoY
The equity has grown by 3.2% from the previous quarter and by 2.9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.